Exhibit 99.1
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, the undersigned agree to the joint filing of a Statement on Schedule 13G (including any and all amendments thereto) with respect to the Common Stock, $0.001 par value per share, of Cyclacel Pharmaceuticals, Inc. and further agree to the filing of this agreement as an exhibit thereto. In addition, each party to this Agreement expressly authorizes each other party to this Agreement to file on its behalf any and all amendments to such Statement on Schedule 13G.
| | | | | |
| TANG CAPITAL PARTNERS, LP | |
| | | |
| | By: | Tang Capital Management, LLC | |
| | Its: | General Partner | |
| | | |
| | By: | /s/ Kevin C. Tang | |
| | | Name: | Kevin C. Tang | |
| | | Title: | Manager | |
| |
| | TANG CAPITAL MANAGEMENT, LLC | |
| | | |
| | By: | /s/ Kevin C. Tang | |
| | | Name: | Kevin C. Tang | |
| | | Title: | Manager | |
| | | |
| | /s/ Kevin C. Tang | |
| | Name: | Kevin C. Tang | |
